levalbuterol HCl

DRUG2 trials

Sponsors

Sumitomo Pharma America, Inc.

Conditions

AsthmaCOPDChronic Obstructive Pulmonary Disease (COPD)

Phase 3

Efficacy and Safety of Levalbuterol in Chronic Obstructive Pulmonary Disease (COPD)

CompletedNCT00665600

Sumitomo Pharma America, Inc.Chronic Obstructive Pulmonary Disease (COPD)

Start: 2002-02-28End: 2003-03-31Updated: 2023-06-27

Phase 4

Costs & Outcomes of Hospitalization/Treatment With Levalbuterol & Albuterol in Asthma or Chronic Obstructive Pulmonary Disease (COPD) Subjects

CompletedNCT00667797

Sumitomo Pharma America, Inc.Asthma, COPD

Start: 2003-03-31End: 2005-05-31Updated: 2012-02-22